Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
07/10/2003 | US20030129582 Method for determining early HCV seroconversion |
07/10/2003 | US20030129295 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
07/10/2003 | US20030129278 Oligosaccharide mixture |
07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
07/10/2003 | CA2471679A1 Negatively charged polysaccharide derivable from aloe vera |
07/10/2003 | CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
07/10/2003 | CA2471348A1 Quinazolinone derivative |
07/10/2003 | CA2471306A1 Secreted proteins |
07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
07/10/2003 | CA2470666A1 Secreted protein |
07/10/2003 | CA2468619A1 Adiponectin fragments and conjugates |
07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
07/09/2003 | EP1325751A1 Novel drugs for liver diseases |
07/09/2003 | EP1325750A1 Preparation of medicines (not lotions) based on olive oil for use as hair growth aid and aid to digestion |
07/09/2003 | EP1325748A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
07/09/2003 | EP1325131A2 A human-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
07/09/2003 | EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins |
07/09/2003 | EP1325112A2 Methods of isolating bipotent hepatic progenitor cells |
07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
07/09/2003 | EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines |
07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
07/09/2003 | EP1325008A1 Piperazine derivatives |
07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
07/09/2003 | EP1324768A2 Vaccines for proliferative ileitis |
07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
07/09/2003 | EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
07/09/2003 | EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses |
07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |
07/09/2003 | CN1429233A Method of preparing clarithromycin of form II crystals |
07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
07/09/2003 | CN1429210A Substituted thioacetamides |
07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
07/09/2003 | CN1429126A Use of cyanoquinolines for treating or inhibiting colonic polyps |
07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
07/09/2003 | CN1428428A Biological reactor using peanut cotyledon as object protein production platform |
07/09/2003 | CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application |
07/09/2003 | CN1428165A Chinese medicine positioning preparation for curing ulcerative colitis |
07/09/2003 | CN1428162A Chinese medicine preparation for curing colitis |
07/09/2003 | CN1428161A Chinese medicine for curing gastopathy |
07/09/2003 | CN1428158A Chinese medicine for curing gastropathy |
07/09/2003 | CN1428150A Tooth-protecting product 3 |
07/09/2003 | CN1428149A Tooth-protecting product 2 |
07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
07/09/2003 | CN1113879C Method for synthesis of benzimidazole compound |
07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
07/09/2003 | CN1113665C Inflammation diminishing and stone dissolving and exhausting liquid and its preparing method |
07/09/2003 | CN1113659C Chinese patent medicine for treating gastritis |
07/09/2003 | CN1113649C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
07/09/2003 | CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation |
07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
07/08/2003 | US6589978 Therapy for nervous system disorders |
07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
07/08/2003 | US6589946 Bile salt conjugates |
07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
07/08/2003 | US6589576 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas) |
07/08/2003 | US6589570 Pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation |
07/08/2003 | US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate |
07/08/2003 | US6589551 Chewable oral unit dosage |
07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
07/08/2003 | US6589525 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells |
07/08/2003 | US6589507 Fast acting; chewable; acid binder, carbon dioxide efferves-cent compound, nonionic surfactant and swellable, gel forming polymer |
07/08/2003 | CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
07/08/2003 | CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
07/08/2003 | CA2090220C Treatment of non-inflammatory and non-infectious bowel disorders |
07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
07/03/2003 | WO2003054012A2 Leptin proteins |
07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
07/03/2003 | WO2003053976A1 PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR |
07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |